Alpha 2.0
Login Register
» Authors » Martin Michl

Martin Michl

Explore the profile of Martin Michl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 72
Followers 0
Related Specialties
Ophthalmology
Chemistry
Biophysics
Top 10 Co-Authors
Ursula Schmidt-Erfurth
Bianca S Gerendas
Berthold Pemp
Nik Krajnc
Gabriel Bsteh
Stefan Macher
Christian Wober
Sina Zaic
Klaus Novak
Wolfgang Marik
Published In
J Headache Pain
Retina
Acta Ophthalmol
J Fluoresc
Angew Chem Int Ed Engl
Affiliations
Soon will be listed here.
Recent Articles
1.
Comparison of AI-based retinal fluid monitoring in neovascular age-related macular degeneration with manual assessment by different eye care professionals under optimized conditions
Michl M, Gerendas B, Gruber A, Goldbach F, Mylonas G, Leingang O, et al.
Acta Ophthalmol . 2025 Feb; PMID: 39950589
Purpose: To investigate whether automated intra- and subretinal fluid (IRF/SRF) volume measurements are equivalent to manual evaluations by eye care professionals from different backgrounds on real-world optical coherence tomography (OCT)...
2.
Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
Deak G, Birner K, Gerendas B, Mylonas G, Weigert G, Michl M, et al.
Sci Rep . 2025 Feb; 15(1):4303. PMID: 39910178
We aimed to compare fluorescein angiography (FA)-based classification of macular neovascularisation (MNV) with optical coherence tomography (OCT)-based classification, as well as examine differences in retinal fluid among OCT MNV types....
3.
Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension
Zaic S, Krajnc N, Macher S, Michl M, Muller N, Mitsch C, et al.
J Headache Pain . 2024 Sep; 25(1):145. PMID: 39237912
Background: Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by increased intracranial pressure. Whilst lumbar puncture (LP) is necessary for the diagnosis of IIH, its therapeutic effect remains unclear....
4.
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension-a comprehensive assessment of clinical outcome
Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Muller N, et al.
Eur J Neurol . 2024 Aug; 31(10):e16401. PMID: 39152571
Background And Purpose: Management of idiopathic intracranial hypertension (IIH) is complex requiring multiple specialized disciplines. In practice, this creates considerable organizational and communicational challenges for healthcare professionals and patients. Thus,...
5.
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - a comprehensive assessment of patient satisfaction
Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Muller N, et al.
J Headache Pain . 2024 Aug; 25(1):127. PMID: 39090530
Background: Management of idiopathic intracranial hypertension (IIH) is complex requiring contributions from multiple specialized disciplines. In practice, this creates considerable organizational and communicational challenges. To meet those challenges, we established...
6.
Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study
Krajnc N, Frank F, Macher S, Michl M, Muller N, Maier S, et al.
J Headache Pain . 2024 Jun; 25(1):92. PMID: 38834953
Background: Idiopathic intracranial hypertension (IIH) is a debilitating condition characterized by increased intracranial pressure often presenting with chronic migraine-like headache. Calcitonin gene-related peptide (CGRP) plays an important pathophysiological role in...
7.
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - an assessment of sick leave, presenteeism, and health care utilization
Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Muller N, et al.
J Headache Pain . 2024 May; 25(1):73. PMID: 38714920
Background: Management of idiopathic intracranial hypertension (IIH) is complex requiring contributions from multiple specialized disciplines. In practice, this creates considerable organizational and communicational challenges. To meet those challenges, we established...
8.
The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI - an external validation study
Macher S, Marik W, Krajnc N, Mitsch C, Michl M, Mueller N, et al.
J Headache Pain . 2024 May; 25(1):70. PMID: 38711044
Background: Recently, diagnostic criteria including a standardized MRI criterion were presented to identify patients suffering from idiopathic intracranial hypertension (IIH) proposing that IIH might be defined by two out of...
9.
Anomaly guided segmentation: Introducing semantic context for lesion segmentation in retinal OCT using weak context supervision from anomaly detection
Seebock P, Orlando J, Michl M, Mai J, Schmidt-Erfurth U, Bogunovic H
Med Image Anal . 2024 Feb; 93:103104. PMID: 38350222
Automated lesion detection in retinal optical coherence tomography (OCT) scans has shown promise for several clinical applications, including diagnosis, monitoring and guidance of treatment decisions. However, segmentation models still struggle...
10.
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, et al.
J Headache Pain . 2023 Jul; 24(1):89. PMID: 37460968
Background: In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option. Methods:...